Publications by authors named "Manceau S"

In children with sickle cell disease (SCD), splenectomy is immediately beneficial for acute sequestration crises and hypersplenism (ASSC/HyS) but portends a long-term risk of asplenia-related complications. We retrieved peripheral and splenic red blood cells (RBCs) from 17 SCD children/teenagers undergoing partial splenectomy for ASSC/HyS, 12 adult subjects without RBC-related disease undergoing splenectomy (controls), five human spleens perfused ex vivo with Hb- and Hb-RBC, and quantified abnormal RBC by microscopy, spleen-mimetic RBC filtration, and adhesion assays. Spleens were analyzed by immunohistochemistry and transmission electron microscopy (TEM).

View Article and Find Full Text PDF

Red blood cells (RBC) transfusion is used to alleviate symptoms and prevent complications in anemic patients by restoring oxygen delivery to tissues. RBC transfusion efficacy, that can be measured by a rise in hemoglobin (Hb) concentration, is influenced by donor-, product-, and recipient-related characteristics. In some studies, severe pre-transfusion anemia is associated with a greater than expected Hb increment following transfusion but the biological mechanism underpinning this relationship remains poorly understood.

View Article and Find Full Text PDF

β-Thalassemia (BT) is one of the most common genetic diseases worldwide and is caused by mutations affecting β-globin production. The only curative treatment is allogenic hematopoietic stem/progenitor cells (HSPCs) transplantation, an approach limited by compatible donor availability and immunological complications. Therefore, transplantation of autologous, genetically-modified HSPCs is an attractive therapeutic option.

View Article and Find Full Text PDF

Given the lack of information about safety of the COVID-19 vaccines for sickle cell disease (SCD) patients, we sought to determine whether COVID-19 vaccine was associated with subsequent hospital admission for vaso-occlusive events (VOEs). We included 402 patients with SCD, including 88 regularly transfused. As of July 31, 2021, 213 (53.

View Article and Find Full Text PDF
Article Synopsis
  • Fanconi anemia (FA) is a genetic disorder that can cause problems like failing bone marrow and a higher risk of cancer.
  • A new study tested using two medicines, G-CSF and plerixafor, to help collect stem cells from people with FA for gene therapy.
  • The results showed that this method was safe and helped gather stem cells more effectively, especially in younger patients without severe bone marrow issues.
View Article and Find Full Text PDF

Introduction: Therapeutic plasma exchange (TPE) is acknowledged to be an effective treatment in life-threatening pediatric disorders. Apheresis for pediatric diseases has been poorly investigated, and most studies to date featured small numbers of patients and lacked control groups. The objective of the present study was to evaluate the tolerance of TPE in pediatric patients.

View Article and Find Full Text PDF

The high prevalence of sickle cell disease in some human populations likely results from the protection afforded against severe malaria and death by heterozygous carriage of HbS. remodels the erythrocyte membrane and skeleton, displaying parasite proteins at the erythrocyte surface that interact with key human proteins in the Ankyrin R and 4.1R complexes.

View Article and Find Full Text PDF

Sperm parameters are known to be impaired in men with sickle cell disease (SCD). Although treatment with hydroxyurea (HU) has an impact on sperm quality, sperm preservation is impossible before puberty. This study's primary objective was to analyze and compare sperm parameters in male patients with SCD exposed (or not) to HU before puberty.

View Article and Find Full Text PDF

Background: Autologous and allogeneic hematopoietic stem cell transplantation of cytokine-mobilized peripheral blood stem cells (PBSCs) is increasingly used to treat patients with hematologic disorders. Different types of vascular access have been exploited for the apheresis procedure, including peripheral veins (PV) and central venous catheter (CVC). In some cases, PV access is unavailable.

View Article and Find Full Text PDF

Iron is required for the oxidative response of neutrophils to allow the production of reactive oxygen species (ROS). However, neutrophil function may be severely altered in conditions of iron overload, as observed in chronically transfused patients. Therefore, a tight regulation of neutrophil iron homeostasis seems to be critical for avoiding iron toxicity.

View Article and Find Full Text PDF
Article Synopsis
  • In African-American patients with sickle cell disease (SCD), specific variants in the APOL1 gene (G1 and G2) significantly increase the risk of developing sickle cell nephropathy (SCN), highlighting the importance of genetic factors in kidney disease.
  • A study of 152 SCD patients in Europe found that homozygous or double-heterozygous genotypes for APOL1 variants were linked to a higher likelihood of end-stage renal disease and worse kidney function, particularly as patients age.
  • The findings suggest that screening for APOL1 variants could be crucial for managing SCD effectively, indicating that individuals with these genetic variants should be monitored more closely for kidney-related complications, regardless of their ethnicity
View Article and Find Full Text PDF

Erythrocytapheresis (ER) can improve outcome in patients with sickle cell disease (SCD). A good vascular access is required but frequently it can be difficult to obtain for sickle cell patients. Arterio-venous fistulas (AVFs) have been suggested for ER in SCD supported by limited evidence.

View Article and Find Full Text PDF

Introduction: Cardiovascular disease is the leading cause of mortality after renal transplantation. The purpose of this study was to analyze cardiovascular risk factors at transplantation, occurrence of cardiovascular events in the first year after transplantation and evaluate pre-transplant work-up.

Material And Method: In total, 244 renal transplant recipients older than 50 years were included.

View Article and Find Full Text PDF

Nowadays, antiretroviral therapy is recommended during pregnancy to prevent mother-to-child transmission of HIV. However, for many antiretroviral drugs, including maraviroc, a CCR5 antagonist, very little data exist regarding placental transfer. Besides, various factors may modulate this transfer, including efflux transporters belonging to the ATP-binding cassette (ABC) transporter superfamily.

View Article and Find Full Text PDF

Objectives: ABC transporters in the human placenta play a major role in protecting the fetus against potential toxic drugs. The glucocorticoid dexamethasone has been shown to induce ABCB1 expression in enterocytes and hepatocytes. However, in placental cells, little data exists either for dexamethasone, betamethasone or prednisone while these three glucocorticoids may be used during pregnancy.

View Article and Find Full Text PDF

The efficacy of drugs acting within lymphocytes, like antiretroviral drugs in the treatment of HIV infection, depends on their intracellular concentrations modulated by efflux proteins like ABCB1 (P-glycoprotein). In lymphocytes, two glucocorticoids, prednisone and prednisolone, have been shown to induce ABCB1 activity. Yet, no data exist regarding dexamethasone (DEX).

View Article and Find Full Text PDF

During the 2009 H1N1 influenza pandemics, the concentrations of oseltamivir (O) and its active metabolite (oseltamivir carboxylate [OC]) were determined in 11 children (1 month to 16 years of age) admitted to intensive care units for presumed severe H1N1 infection. They received oseltamivir phosphate (OP) nasogastrically at doses between 1.5 and 6.

View Article and Find Full Text PDF

The efficacy of drugs acting within lymphocytes depends on their intracellular concentrations, which could be modulated by membrane efflux transporters including P-glycoprotein (P-gp), encoded by the MDR1 gene. In particular, P-gp induction may compromise the efficacy of its substrates. Rifampicin and phenobarbital have been shown to induce P-gp in hepatic and intestinal cells through the activation of the nuclear receptors PXR and CAR.

View Article and Find Full Text PDF

Importance Of The Field: ATP-binding cassette (ABC) transporters are a superfamily of efflux pumps that transport numerous compounds across cell membranes. These transporters are located in various human tissues including peripheral blood cells, in particular lymphocytes, and present a high variability of expression and activity. This variability may affect the intracellular concentrations and efficacy of drugs acting within lymphocytes, such as antiretroviral drugs.

View Article and Find Full Text PDF
Article Synopsis
  • The effectiveness of drugs that target lymphocytes, such as anticancer and antiretroviral medications, relies on their levels within cells, which can be influenced by ABC transporter proteins.
  • Gene expression analysis of six key ABC transporters (MDR1, MRP1, MRP3, MRP4, MRP5, and BCRP) in lymphocytes revealed that MRP1 and MRP5 were most expressed in adults, while BCRP and MRP4 had higher levels at birth compared to after one month.
  • The study found that HIV infection and antiretroviral treatments did not significantly affect the expression of these transporters, suggesting that certain drugs for newborns, like zidovudine, may not
View Article and Find Full Text PDF

P-glycoprotein (P-gp) is an efflux transporter that controls the intracellular concentrations of drugs. Human development may modulate P-gp function. We investigated the effect of age on P-gp activity and MDR1 gene expression in lymphocytes.

View Article and Find Full Text PDF